Catherine joined Lumanity in August 2025. She serves as a project leader and strategic advisor to Lumanity teams and global life sciences clients, translating health economics and outcomes research (HEOR) and value evidence into clear access strategies that support payer engagement, launch readiness, and sustained product differentiation.
Her expertise spans the full spectrum of value demonstration, including evidence strategy, scientific messaging, and value story development for global market access submissions. Catherine is recognized for translating complex data into clear, compelling value propositions that address payer concerns and support favorable coverage decisions. She has supported product launches across multiple therapy areas, including oncology, rare diseases and immunology. She is passionate about advancing access to transformative therapies, and ensuring healthcare innovation delivers both clinical and economic value.
Before joining Lumanity, Catherine spent nearly two decades at a global research and consulting firm. In this role and across progressively senior positions, she led strategic HEOR and market access planning for pipeline and in-line assets across pharmaceutical, biotechnology, and medical device clients, directing value demonstration and evidence generation strategies aligned with global regulatory and reimbursement requirements. She also developed payer communication tools and market access frameworks to support early value planning and product launches. Earlier in her career, she held roles in industry and payer organizations, building outcomes-focused evidence, economic models, and analytics to support access decision-making.
Catherine holds an MPH in Health Policy and Administration from the Yale School of Public Health, a BS in Psychobiology from UCLA, and the Stanford LEAD: Corporate Innovation Certificate from Stanford Graduate School of Business.